Private Equity-Venture Capital (PE-VC) investments recorded a 27% growth year-on-year during Jan-April this year at $11.8 billion against $9.3 billion.

CHICAGO, IL / ACCESS Newswire / April 30, 2025 / Risen Pharma, a clinical stage biotech company focusing on developing treatments that address mechanisms of therapeutic resistance, today announced ...